Bio-Rad Laboratories (BIO) Current Deferred Revenue (2010 - 2022)
Bio-Rad Laboratories (BIO) posted quarterly Current Deferred Revenue of $71.9 million for Q4 2022, up 41.39% year-over-year from $50.9 million in Q4 2021, and up 41.39% quarter-over-quarter from $50.9 million in Q4 2021.
Bio-Rad Laboratories (BIO) Current Deferred Revenue (2010 - 2022) Analysis & Trends
Bio-Rad Laboratories (BIO) has reported Current Deferred Revenue for 13 consecutive years, with $71.9 million the latest figure, recorded in Q4 2022.
- In Q4 2022, Current Deferred Revenue rose 41.39% year-over-year to $71.9 million; the TTM figure through Dec 2022 stood at $71.9 million (up 41.39% YoY), while the FY2022 annual figure was $71.9 million, up 41.39% from the prior year.
- Current Deferred Revenue climbed to $71.9 million in Q4 2022 per BIO's latest filing, from $50.9 million in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $71.9 million in Q4 2022 and bottomed at $26.9 million in Q4 2018.
- Historically, Current Deferred Revenue has averaged $44.4 million across 5 years, with a median of $42.5 million in 2020.
- Annual changes were most pronounced in 2018 — Current Deferred Revenue dropped 26.6% — and 2022, when it surged 41.39%.
- Bio-Rad Laboratories' Current Deferred Revenue stood at $26.9 million in 2018, then climbed by 25.11% to $33.7 million in 2019, then rose by 26.02% to $42.5 million in 2020, then grew by 19.74% to $50.9 million in 2021, then soared by 41.39% to $71.9 million in 2022.
- Business Quant data shows BIO's Current Deferred Revenue at $71.9 million in Q4 2022, $50.9 million in Q4 2021, and $42.5 million in Q4 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn |
| 10 | Bio-Rad Laboratories | 10.10 Bn | 8.48 Bn | 345.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 71.90 Mn |
| Dec 31, 2021 | 50.85 Mn |
| Dec 31, 2020 | 42.47 Mn |
| Jun 30, 2020 | 51.00 Mn |
| Mar 31, 2020 | 50.90 Mn |
| Dec 31, 2019 | 33.70 Mn |
| Sep 30, 2019 | 45.60 Mn |
| Jun 30, 2019 | 44.40 Mn |
| Mar 31, 2019 | 41.10 Mn |
| Dec 31, 2018 | 26.94 Mn |
| Sep 30, 2018 | 39.30 Mn |
| Jun 30, 2018 | 41.40 Mn |
| Mar 31, 2018 | 38.20 Mn |
| Dec 31, 2017 | 36.70 Mn |
| Dec 31, 2016 | 31.00 Mn |
| Dec 31, 2015 | 29.68 Mn |
| Dec 31, 2014 | 26.72 Mn |
| Dec 31, 2013 | 26.39 Mn |
| Dec 31, 2012 | 26.29 Mn |
| Dec 31, 2011 | 24.32 Mn |